Announcements Trials
Browse Landscape

Phase

Phase NA 35Phase 4 14Phase 2/3 4Phase 3 2Phase 2 2

Status

Unknown 2Completed 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Pheochromocytoma 1Obesity 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Dexmedetomidine × Clear all
NCT04730375 2022-05-05

Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients

National Cancer Institute, Egypt

Phase 2 Completed
70 enrolled
Other

Obesity

NCT04320589 2021-09-01

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

National Cancer Institute, Egypt

Phase 2 Completed
30 enrolled
Endocrine

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡